In this issue
-
One Health approach: human, animal and environmental health united
Antimicrobial resistance (AMR) is a complex public health matter that asks for complex solutions, and it disproportionately impacts marginalised populations across countries. The pronouncement about the threat of Antimicrobial Resistance (AMR) is real. It continues to put unprecedented pressure on health and care services in Europe, widens health inequities in a post-pandemic society and goes...
-
The AMR PULL incentive: keep calm but go quick
AMR will not be solved without innovation. No innovation is possible without attractive market conditions. This duality is now well understood by the political world, which has already started to work. The threat of antimicrobial resistance continues to grow. The number of resistant infections is growing by 20% a year in Europe and is causing...
-
Why the UN High-Level Meeting is critical to the fight against AMR
Next year, the United Nations will hold a High-Level Meeting (HLM) to discuss the global coordination necessary to tackle antimicrobial resistance (AMR). The rise of AMR continues to be one of the biggest threats to global health and modern medicine. An estimated 1.2 million people die from antibiotic-resistant bacterial infections every year, and this resistance...
-
s Sponsored
Mobilising political commitment and action on antimicrobial resistance
Without a long-term and multisectoral response to AMR, the prevalence and impact of drug-resistant pathogens — on human, animal and plant health; environmental ecosystems; food production; livelihoods; and economies — will inevitably grow. The Global Leaders Group (GLG) on antimicrobial resistance (AMR) was established in 2020 to advocate for and help mobilise greater political commitment...
-
s Sponsored
Cooperate at a large scale or fail: the tragedy of antimicrobial resistance
Antimicrobial resistance (AMR) is a priority — yet an unresolved — global health problem. Antimicrobials have helped reduce the individual and societal impact of many diseases. Therefore, the loss in the ability to effectively prevent and treat infections with antimicrobials that follows from a rise in AMR will significantly reduce the advantages achieved in modern...
-
s Sponsored
Holistic infection management: tackling the challenge of sepsis and AMR
When considering how to better address sepsis – which already affects 250,000 people in the UK each year, with 52,000 people dying as a result, we need to consider infection management holistically.1 The growing threat of antimicrobial resistance (AMR) is a critical public health concern and a major challenge in the treatment of sepsis. As...
-
How can diagnostic tests help with antimicrobial resistance in the UK?
Tackling antimicrobial resistance (AMR) is truly like fighting a monster with many heads — AMR is a global threat, much like climate change with many causes and no single solution even for each country. Diagnostic tests are an important tool to help reduce AMR. These tests are done on samples from the body such as...
-
s Sponsored
Biggest AMR dilemma: to give, or not to give antibiotics?
The misdiagnosis of sepsis is leading to an overuse of antibiotics, but early and accurate diagnostics using point-of-care biomarkers can address this problem. The two main reasons for the use of antibiotics are the treatment and the prevention of bacterial infections. Overuse of antibiotics Sepsis (a dysregulated reaction of the body to infection with 50...
-
s Sponsored
How can rapid, effective diagnostics help in the fight against antimicrobial resistance?
Accurate, rapid infection diagnosis supports healthcare teams to get people the care they need quickly and reduce the impact of AMR. Antimicrobial resistance (AMR) is a widespread concern in the UK; we must use current antimicrobials wisely to reduce the risk of AMR infections to patients. Accurate, rapid diagnostic tests support healthcare teams to identify...
-
s Sponsored
The role of the environment in the fight against AMR
Much of the global coordination on combatting AMR has rightly been focused on incentives, appropriate use, stewardship, diagnostics and other tools. But we must also consider the environmental dimension of antimicrobial resistance. With over 100 members, the AMR Industry Alliance is the largest life-sciences coalition providing sustainable solutions to curb AMR, including awareness raising and...
Global Cause